Historical review: A brief history and personal retrospective of seven-transmembrane receptors

Trends in Pharmacological Sciences

Volumn 25, Issue 8, 2004, Pages 413-422

  Lefkowitz, Robert J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ARRESTIN; CHIMERIC PROTEIN; COMPLEMENTARY DNA; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RADIOLIGAND; RETINA S ANTIGEN; RHODOPSIN;

AFFINITY CHROMATOGRAPHY; ARCHITECTURE; BINDING AFFINITY; BIOCHEMISTRY; BIOTECHNOLOGY; CARDIOVASCULAR EFFECT; CRYSTALLIZATION; DESENSITIZATION; DIMERIZATION; ENDOCYTOSIS; GENE CONSTRUCT; GENE LIBRARY; LIGAND BINDING; MOLECULAR CLONING; MOLECULAR MECHANICS; MUTAGENESIS; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR GENE; RECEPTOR SENSITIVITY; RECEPTOR SOLUBILIZATION; RETROSPECTIVE STUDY; REVIEW; SECOND MESSENGER; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STEREOSPECIFICITY;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; MEMBRANE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 3242793327     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.06.006     Document Type: Review

References (104)

1. Pierce K.L., et al. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3:2002;639-650
2. Fredriksson R., et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63:2003;1256-1272
3. Gudermann T., et al. Receptors and G proteins as primary components of transmembrane signal transduction. Part 1. G-protein-coupled receptors: structure and function. J. Mol. Med. 73:1995;51-63
4. Limbird L.E. Historical perspective. Limbird L.E. Cell Surface Receptors: A Short Course on Theory and Methods. 1996;1-26 Kluwer Academic
5. Langley J.N. Observations on the physiological action of extracts of the supra-renal bodies. J. Physiol. (Lond.). 17:1901;231-256
6. Dale H.H. On some physiological actions of ergot. J. Physiol. (Lond.). 34:1906;163-206
7. Furchgott R.F. Receptor mechanisms. Annu. Rev. Pharmacol. 4:1964;21-50
8. Sutherland E.W. Cyclic AMP. Robison G.A.,, et al. An Introduction. 1971;5-13 Academic Press
9. Walsh D.A., et al. An adenosine 3′,5′-monophosphate-dependent protein kinase from rabbit skeletal muscle. J. Biol. Chem. 243:1968;3763-3765
10. Rodbell M., et al. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J. Biol. Chem. 246:1971;1877-1882
11. Ross E.M., Gilman A.G. Resolution of some components of adenylate cyclase necessary for catalytic activity. J. Biol. Chem. 252:1977;6966-6969
12. Gilman A.G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:1987;615-649
13. Ahlquist R.P. Adrenergic receptors: a personal and practical view. Perspect. Biol. Med. 17:1973;119-122
14. Robison G.A., et al. Adenyl cyclase as an adrenergic receptor. Ann. New York Acad. Sci. 139:1967;703-723
15. Devillers-Thiery A., et al. Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J. Membr. Biol. 136:1993;97-112
16. Dohlman H.G., et al. Model systems for the study of seven-transmembrane- segment receptors. Annu. Rev. Biochem. 60:1991;653-688
17. Lefkowitz R.J., et al. β-Adrenergic receptors and rhodopsin: shedding new light on an old subject. Trends Pharmacol. Sci. 7:1986;444-448
18. Stryer L. Cyclic GMP cascade of vision. Annu. Rev. Neurosci. 9:1986;87-119
19. Sobel A., et al. Large-scale purification of the acetylcholine-receptor protein in its membrane-bound and detergent-extracted forms from Torpedo marmorata electric organ. Eur. J. Biochem. 80:1977;215-224
20. Black J. Nobel lecture in physiology or medicine-1988. Drugs from emasculated hormones: the principle of syntopic antagonism. In Vitro Cell. Dev. Biol. 25:1989;311-320
21. Snyder S.H., Pasternak G.W. Historical review: Opioid receptors. Trends Pharmacol. Sci. 24:2003;198-205
22. De Lean A., et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 255:1980;7108-7117
23. Kent R.S., et al. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17:1980;14-23
24. Mickey J., et al. Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (-)isoproterenol in vitro. J. Biol. Chem. 250:1975;5727-5729
25. Caron M.G., et al. Affinity chromatography of the beta-adrenergic receptor. J. Biol. Chem. 254:1979;2923-2927
26. Shorr R.G., et al. Purification of the beta-adrenergic receptor. Identification of the hormone binding subunit. J. Biol. Chem. 256:1981;5820-5826
27. Benovic J.L., et al. The mammalian beta 2-adrenergic receptor: purification and characterization. Biochemistry. 23:1984;4510-4518
28. Regan J.W., et al. Purification and characterization of the human platelet alpha 2-adrenergic receptor. J. Biol. Chem. 261:1986;3894-3900
29. Lomasney J.W., et al. Mammalian alpha 1-adrenergic receptor. Purification and characterization of the native receptor ligand binding subunit. J. Biol. Chem. 261:1986;7710-7716
30. Cerione R.A., et al. Reconstitution of beta-adrenergic receptors in lipid vesicles: affinity chromatography-purified receptors confer catecholamine responsiveness on a heterologous adenylate cyclase system. Proc. Natl. Acad. Sci. U. S. A. 80:1983;4899-4903
31. Cerione R.A., et al. Reconstitution of a hormone-sensitive adenylate cyclase system. The pure beta-adrenergic receptor and guanine nucleotide regulatory protein confer hormone responsiveness on the resolved catalytic unit. J. Biol. Chem. 259:1984;9979-9982
32. May D.C., et al. Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J. Biol. Chem. 260:1985;15829-15833
33. Dixon R.A., et al. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature. 321:1986;75-79
34. Kobilka B.K., et al. Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J. Biol. Chem. 262:1987;7321-7327
35. Kobilka B.K., et al. Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science. 238:1987;650-656
36. Pepitoni S., et al. Structure of the m1 muscarinic acetylcholine receptor gene and its promoter. J. Biol. Chem. 272:1997;17112-17117
37. Sunahara R.K., et al. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature. 347:1990;80-83
38. Ovchinnikov Y.A. Rhodopsin and bacteriorhodopsin: structure-function relationships. FEBS Lett. 148:1982;179-191
39. Hargrave P.A., et al. The structure of bovine rhodopsin. Biophys. Struct. Mech. 9:1983;235-244
40. Henderson R., Unwin P.N. Three-dimensional model of purple membrane obtained by electron microscopy. Nature. 257:1975;28-32
41. Dohlman H.G., et al. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry. 26:1987;2657-2664
42. Frielle T., et al. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 84:1987;7920-7924
43. Regan J.W., et al. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6301-6305
44. Cotecchia S., et al. Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7159-7163
45. Schwinn D.A., et al. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J. Biol. Chem. 265:1990;8183-8189
46. Lomasney J.W., et al. Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc. Natl. Acad. Sci. U. S. A. 87:1990;5094-5098
47. Lomasney J.W., et al. Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. J. Biol. Chem. 266:1991;6365-6369
48. Lefkowitz, R.J. and Caron, M.G. (1989) The Adrenergic Receptors. In Proceedings of The Robert A. Welch Foundation Conferences on Chemical Research, XXXIII, pp. 183-199.
49. Fukuda K., et al. Molecular distinction between muscarinic acetylcholine receptor subtypes. Nature. 327:1987;623-625
50. Masu Y., et al. cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature. 329:1987;836-838
51. Kobilka B.K., et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 329:1987;75-79
52. Fargin A., et al. The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature. 335:1988;358-360
53. Buck L., Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell. 65:1991;175-187
54. Ostrowski J., et al. Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. Annu. Rev. Pharmacol. Toxicol. 32:1992;167-183
55. Strader C.D., et al. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:1994;101-132
56. Parmentier M., et al. Molecular cloning of the thyrotropin receptor. Science. 246:1989;1620-1622
57. Vu T.K., et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068
58. Kobilka B.K., et al. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 240:1988;1310-1316
59. Cotecchia S., et al. Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J. Biol. Chem. 267:1992;1633-1639
60. Kjelsberg M.A., et al. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267:1992;1430-1433
61. Spiegel A.M. G Proteins, Receptors, and Disease. 1998;Humana Press
62. Costa T., Herz A. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7321-7325
63. Bond R.A., et al. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature. 374:1995;272-276
64. Wilden U., Kuhn H. Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites. Biochemistry. 21:1982;3014-3022
65. Stadel J.M., et al. Catecholamine-induced desensitization of turkey erythrocyte adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 80:1983;3173-3177
66. Shichi H., Somers R.L. Light-dependent phosphorylation of rhodopsin. Purification and properties of rhodopsin kinase. J. Biol. Chem. 253:1978;7040-7046
67. Benovic J.L., et al. Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J. Biol. Chem. 260:1985;7094-7101
68. Benovic J.L., et al. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. U. S. A. 83:1986;2797-2801
69. Wilden U., et al. Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc. Natl. Acad. Sci. U. S. A. 83:1986;1174-1178
70. Zuckerman R., et al. Arrestin mediates ATP/ADP exchange and quench of cGMP phosphodiesterase activation. Invest. Ophthalmol. Vis. Sci. (Suppl.). 26:1985;45
71. Benovic J.L., et al. Purification and characterization of the beta-adrenergic receptor kinase. J. Biol. Chem. 262:1987;9026-9032
72. Benovic J.L., et al. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc. Natl. Acad. Sci. U. S. A. 84:1987;8879-8882
73. Shinohara T., et al. Primary and secondary structure of bovine retinal S antigen (48-kDa protein). Proc. Natl. Acad. Sci. U. S. A. 84:1987;6975-6979
74. Lohse M.J., et al. beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 248:1990;1547-1550
75. Attramadal H., et al. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J. Biol. Chem. 267:1992;17882-17890
76. Benovic J.L., et al. Light-dependent phosphorylation of rhodopsin by beta-adrenergic receptor kinase. Nature. 321:1986;869-872
77. Benovic J.L., et al. Beta-adrenergic receptor kinase: primary structure delineates a multigene family. Science. 246:1989;235-240
78. Lorenz W., et al. The receptor kinase family: primary structure of rhodopsin kinase reveals similarities to the beta-adrenergic receptor kinase. Proc. Natl. Acad. Sci. U. S. A. 88:1991;8715-8719
79. Lefkowitz R.J. G protein-coupled receptor kinases. Cell. 74:1993;409-412
80. Pitcher J.A., et al. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67:1998;653-692
81. Willets J.M., et al. Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol. Sci. 24:2003;626-633
82. Kohout T.A., Lefkowitz R.J. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63:2003;9-18
83. Shenoy S.K., Lefkowitz R.J. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 375:2003;503-515
84. Perry S.J., Lefkowitz R.J. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 12:2002;130-138
85. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53:2001;1-24
86. Shenoy S.K., et al. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 294:2001;1307-1313
87. Luttrell L.M., et al. β-arrestin-dependent formation of β2-adrenergic receptor/Src kinase complexes and mitogenic signaling. Science. 283:1999;655-661
88. Luttrell L.M., et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2449-2454
89. Sun Y., et al. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277:2002;49212-49219
90. McDonald P.H., et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 290:2000;1574-1577
91. Goel R., et al. alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression. J. Biol. Chem. 277:2002;18640-18648
92. Povsic T.J., et al. Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J. Biol. Chem. 278:2003;51334-51339
93. Lin F.T., et al. beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J. Biol. Chem. 273:1998;31640-31643
94. Tohgo A., et al. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277:2002;9429-9436
95. Tohgo A., et al. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 278:2003;6258-6267
96. Fong A.M., et al. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7478-7483
97. Palczewski K., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 289:2000;739-745
98. Hirsch J.A., et al. The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell. 97:1999;257-269
99. Lodowski D.T., et al. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. Science. 300:2003;1256-1262
100. Angers S., et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42:2002;409-435
101. Lee D.K., et al. Continued discovery of ligands for G protein-coupled receptors. Life Sci. 74:2003;293-297
102. Brady A.E., Limbird L.E. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal. 14:2002;297-309
103. Samson M., et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725
104. Mialet Perez, J. et al. (2003) Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat. Med. 9, 1300-1305.